Laboratory of Reproductive Biology, Juliane Marie Center for Women, Children, and Reproduction, University Hospital of Copenhagen, Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark.
Laboratory of Reproductive Biology, Juliane Marie Center for Women, Children, and Reproduction, University Hospital of Copenhagen, Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark.
Fertil Steril. 2017 May;107(5):1206-1213. doi: 10.1016/j.fertnstert.2017.03.017. Epub 2017 Apr 19.
To report the first successful refreezing of ovarian tissue recovered more than 3 years after transplantation in a woman previously treated for early-stage ovarian cancer.
Evaluation of cryopreserved and grafted ovarian tissue.
University hospital.
PATIENT(S): A 23-year-old woman diagnosed with stage 1C ovarian mucinous cystadenocarcinoma.
INTERVENTION(S): The patient underwent ovarian tissue cryopreservation for fertility preservation and subsequent heterotopic transplantation for fertility restoration 9 years after freezing. After a successful IVF twin pregnancy, grafted tissue was laparoscopically removed for safety reasons. The recovered tissue was refrozen.
MAIN OUTCOME MEASURE(S): Live birth and histologic evaluation of the distribution of pre-antral follicle stages.
RESULT(S): The previously grafted ovarian tissue was successfully refrozen, presenting follicular survival 4 weeks after xenografting. The follicular distribution in the recovered grafts showed a shift toward growing-stage follicles compared with the fresh tissue. The patient subsequently entered menopause, and histologic evaluation revealed a total of five follicles in two remaining grafts which had supported ovarian function a few months earlier.
CONCLUSION(S): This is the second case of delivery following heterotopic grafting as well as the second case of successful transplantation of ovarian tissue from a patient with early-stage ovarian cancer. The recovered grafts showed that a lower number of functional follicles than previously estimated can actually support ovarian function. Removing and refreezing grafted tissue could be a new way of handling not only cancer patients with a risk of malignant cell recurrence, but also certain groups of patients with genetic conditions.
报告首例在接受早期卵巢癌治疗的女性中,在移植后 3 年以上成功对卵巢组织进行再冷冻的病例。
对冷冻和移植的卵巢组织进行评估。
大学医院。
一名 23 岁的女性,诊断为 1C 期卵巢黏液性囊腺癌。
该患者接受了卵巢组织冷冻保存以进行生育力保存,并在冷冻 9 年后进行了异基因移植以恢复生育力。在一次成功的 IVF 双胞胎妊娠后,出于安全原因,对移植的组织进行了腹腔镜切除。回收的组织被重新冷冻。
活产和原始卵泡阶段分布的组织学评估。
先前移植的卵巢组织成功再冷冻,异种移植后 4 周出现卵泡存活。与新鲜组织相比,回收的移植物中的卵泡分布向生长阶段的卵泡转移。随后患者进入更年期,组织学评估显示在两个剩余移植物中共有五个卵泡,这两个移植物在几个月前曾支持卵巢功能。
这是第二例接受异基因移植后分娩的病例,也是第二例成功移植早期卵巢癌患者卵巢组织的病例。回收的移植物表明,实际支持卵巢功能的功能性卵泡数量比之前估计的要少。切除和再冷冻移植组织可能是一种新的方法,不仅可以处理有恶性细胞复发风险的癌症患者,还可以处理某些遗传条件的患者。